import React from "react";
import { useEffect } from "react";
import NutritionHeader from "../../components/partials/Header/nutritionsheader";
import "@fortawesome/fontawesome-free/css/all.min.css";
import "../../assets/css/nutrition.css";
import "../../assets/css/blog.css";
import NutritionFooter from "../../components/partials/Footer/nutritionfooter";
import { Link } from "react-router-dom";
import { Helmet } from "react-helmet";

function FromFSSAItoCDSCOIstheRegulationofIndianNutraceuticalsChangingIn() {
  const canonicalUrl = window.location.href;
  useEffect(() => {
    const $ = window.$;
    $(".owl-prev").html('<i class="fas fa-arrow-left"></i>');
    $(".owl-next").html('<i class="fas fa-arrow-right"></i>');
  }, []);
  return (
    <>
      <Helmet>
        <title>
          FSSAI vs CDSCO: The 2026 Regulatory Shift in Indian Nutraceuticals
        </title>
        <meta
          name="description"
          content="Explore the major 2026 updates in India’s nutraceutical regulations. Learn how the shift from FSSAI to CDSCO affects health claims, licensing, and the role of third-party nutraceutical manufacturing in ensuring brand compliance."
        />
        <meta
          name="keyword"
          content="private label supplements, white label supplements, supplement brand, nutraceutical manufacturing, FSSAI license, supplement business"
        />
        <meta
          property="og:title"
          content="FSSAI vs CDSCO: The 2026 Regulatory Shift in Indian Nutraceuticals"
        />
        <meta
          property="og:description"
          content="Explore the major 2026 updates in India’s nutraceutical regulations. Learn how the shift from FSSAI to CDSCO affects health claims, licensing, and the role of third-party nutraceutical manufacturing in ensuring brand compliance."
        />
        <meta
          property="og:image"
          content="https://fggroup.in/assets/images/logo/fg_group.webp"
        />
        <meta property="og:url" content={canonicalUrl} />
        <link rel="canonical" href={canonicalUrl} />
        <script>
          {`!function(f,b,e,v,n,t,s)
                                 {if(f.fbq)return;n=f.fbq=function(){n.callMethod?
                                 n.callMethod.apply(n,arguments):n.queue.push(arguments)};
                                 if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0';
                                 n.queue=[];t=b.createElement(e);t.async=!0;
                                 t.src=v;s=b.getElementsByTagName(e)[0];
                                 s.parentNode.insertBefore(t,s)}(window, document,'script',
                                 'https://connect.facebook.net/en_US/fbevents.js');
                                 fbq('init', '1144699046738070');
                                 fbq('track', 'PageView');
                                 `}
        </script>
        <noscript>
          {`<img height="1" width="1" style="display:none"
                                 src="https://www.facebook.com/tr?id=1144699046738070&ev=PageView&noscript=1"
                                 />`}
        </noscript>
        <script
          async
          src={`https://www.googletagmanager.com/gtag/js?id=G-J50WNKGW38`}
        ></script>
        <noscript>{`window.dataLayer = window.dataLayer || [];
                             function gtag(){dataLayer.push(arguments);}
                             gtag('js', new Date());
                             gtag('config', 'G-J50WNKGW38');`}</noscript>
      </Helmet>
      <NutritionHeader />
      <div className="my-auto">
        <section className="header-main">
          <div className="px-1 py-2 bg-yellow text-center">
            <div className="item active">
              <Link to="/nutrition/bulk-inquiry-nutrition">
                <p className="text-white m-0 f-rob-reg f-14 lp-2">
                  Bulk Inquiry Now
                </p>
              </Link>
            </div>
          </div>
        </section>
      </div>
      <div className="main-content mb-150">
        <section className="blog-main">
          <div className="container-fluid  p-0 w-95">
            <div className="row">
              <div className="col-12 text-center p-0-p-15">
                <div className="details-banner-img position-relative">
                  <img
                    src={
                      process.env.PUBLIC_URL +
                      "/assets/images/white-labelling-blogs/what-supplements-1.webp"
                    }
                    alt="bgImage"
                    className="img-fluid w-100 mh-200 object-fit blog-img-inner-main"
                  />
                  <div className="layer"></div>
                  <div className="col-12 detail-title">
                    <h1 className="text-white f-rob-bol f-43">
                      From FSSAI to CDSCO: Is the Regulation of Indian
                      Nutraceuticals Changing in 2026?
                    </h1>
                  </div>
                </div>
              </div>
            </div>
          </div>

          <div className="container-fluid w-80">
            <div className="row">
              <div className="col-12 text-center mb-4 px-4">
                <div className="ql-editor text-left mt-5">
                  <div className="blog-container">
                    <div className="blog-section">
                      <p className="blog-text mb-8">
                        For nearly a decade, the Indian nutraceutical sector
                        operated under a relatively flexible framework. However,
                        as we move through 2026, a significant transformation is
                        taking place.
                      </p>
                      <p className="blog-text mb-8">
                        The Ministry of Health's recent inter-ministerial
                        committee recommendations have initiated a transition
                        that moves high-potency supplements from the Food Safety
                        and Standards Authority of India (FSSAI) to the Central
                        Drugs Standard Control Organization (CDSCO).
                      </p>
                      <p className="blog-text mb-8">
                        For brand owners, this isn't just a name change on a
                        license; it is a fundamental shift in how products are
                        formulated, labeled, and sold.
                      </p>
                    </div>

                    <div className="blog-section">
                      <h2 className="blog-section-title">
                        The New Boundary: Wellness vs. Therapy
                      </h2>
                      <p className="blog-text mb-8">
                        The primary objective of the 2026 update is to eliminate
                        the "grey area" where supplements masquerade as
                        medicines. The regulation now follows a clear
                        demarcation based on intent and dosage:
                      </p>
                      <ul className="blog-list">
                        <li>
                          <strong>The FSSAI Domain:</strong> Remains the
                          regulator for general health supplements, vitamins,
                          and minerals that fall within the Recommended Dietary
                          Allowance (RDA). If your product is meant for general
                          wellness, FSSAI is your home.
                        </li>
                        <li>
                          <strong>The CDSCO Domain:</strong> Now oversees any
                          product making{" "}
                          <strong>Disease Risk Reduction (DRR)</strong> claims.
                          If a product is marketed to "treat," "cure," or
                          "mitigate" conditions like diabetes or hypertension,
                          it is now classified as a drug.
                        </li>
                      </ul>
                    </div>

                    <div className="blog-section">
                      <h2 className="blog-section-title">
                        Impact on Product Formulation and Claims
                      </h2>
                      <p className="blog-text mb-8">
                        Under the 2026 guidelines, manufacturers can no longer
                        use vague terms like "immunity-boosting" or "natural
                        healer" without rigorous scientific backing.
                      </p>
                      <p className="blog-text mb-8">
                        The FSSAI now requires mandatory submission of stability
                        studies and toxicological data for all "non-specified"
                        food ingredients.
                      </p>
                      <p className="blog-text mb-8">
                        Furthermore, ingredients that have a pharmacological
                        effect — previously found in a regulatory loophole — are
                        being reassessed.
                      </p>
                      <p className="blog-text mb-8">
                        This shift ensures that high-dose botanicals and
                        specialized extracts are manufactured with the same
                        precision as pharmaceuticals.
                      </p>
                    </div>

                    <div className="blog-section">
                      <h2 className="blog-section-title">
                        The Great Divide: FSSAI vs. CDSCO for Nutraceuticals
                      </h2>
                      <p className="blog-text mb-8">
                        The core of the 2026 regulatory change lies in the
                        recommendations of the inter-ministerial committee,
                        which seeks to end the "regulatory overlap" that has
                        confused the industry for years.
                      </p>
                      <p className="blog-text mb-8">
                        The shift toward CDSCO oversight for therapeutic
                        products is a response to the growing need for stricter
                        standards in the industry, as detailed in this article:{" "}
                        <strong>
                          <Link
                            className="blog-text-link"
                            to="https://www.pharmabiz.com/ArticleDetails.aspx?aid=183948&sid=9"
                          >
                            regulatory update on Indian nutraceuticals
                          </Link>
                        </strong>
                      </p>

                      <h3 className="blog-subsection-title">
                        1. FSSAI: The Home for "Wellness and Prevention"
                      </h3>
                      <p className="blog-text mb-8">
                        Under the new guidelines, FSSAI remains the sole
                        authority for products that serve a nutritional purpose.
                      </p>
                      <ul className="blog-list">
                        <li>
                          <strong>Scope:</strong> Health supplements, functional
                          foods, and vitamins that stay within the{" "}
                          <strong>
                            100% Recommended Dietary Allowance (RDA)
                          </strong>{" "}
                          limits.
                        </li>
                        <li>
                          <strong>Target:</strong> General wellness, immunity
                          support, and filling nutritional gaps.
                        </li>
                        <li>
                          <strong>Standard:</strong> Regulated as "Food." The
                          focus is on safety, hygiene, and labeling compliance.
                        </li>
                      </ul>

                      <h3 className="blog-subsection-title">
                        2. CDSCO: The New Authority for "Therapeutic
                        Intervention"
                      </h3>
                      <p className="blog-text mb-8">
                        The most significant shift is the move of high-potency
                        products to the <strong>CDSCO</strong> (Central Drugs
                        Standard Control Organization). This is no longer a
                        suggestion; it is a structural mandate for products
                        crossing into the "Drug" territory.
                      </p>
                    </div>

                    <div className="blog-section">
                      <h2 className="blog-section-title">
                        The Strategic Role of Manufacturing Partners
                      </h2>
                      <p className="blog-text mb-8">
                        With these tightening rules, the technical burden on
                        brands has increased. This is where choosing a
                        sophisticated{" "}
                        <strong>
                          <Link
                            className="blog-text-link"
                            to="https://www.gomzilifesciences.in/nutrition/white-labelling"
                          >
                            third-party nutraceutical manufacturing in India
                          </Link>
                        </strong>{" "}
                        partner becomes vital. In 2026, a manufacturer is no
                        longer just a vendor; they are your compliance shield.
                      </p>
                      <p className="blog-text mb-8">
                        A professional manufacturing unit helps navigate these
                        changes by:
                      </p>
                      <ul className="blog-list">
                        <li>
                          Ensuring formulations stay within the legal RDA limits
                          to avoid being flagged by CDSCO.
                        </li>
                        <li>
                          Providing NABL-accredited lab reports that are now
                          mandatory for batch clearance.
                        </li>
                        <li>
                          Implementing "Schedule M" equivalent GMP standards,
                          which are increasingly expected even for food-category
                          supplements.
                        </li>
                      </ul>
                    </div>

                    <div className="blog-section">
                      <h2 className="blog-section-title">
                        A professional manufacturing unit helps navigate these
                        changes by:{" "}
                      </h2>

                      <ul className="blog-list">
                        <li>
                          Ensuring formulations stay within the legal RDA limits
                          to avoid being flagged by CDSCO.
                        </li>
                        <li>
                          Providing NABL-accredited lab reports that are now
                          mandatory for batch clearance.
                        </li>
                        <li>
                          Implementing "Schedule M" equivalent GMP standards,
                          which are increasingly expected even for food-category
                          supplements.
                        </li>
                      </ul>
                    </div>

                    <div className="blog-section">
                      <h2 className="blog-section-title">
                        Why This Shift Benefits the Industry
                      </h2>
                      <p className="blog-text mb-8">
                        While the transition to CDSCO oversight for therapeutic
                        supplements adds a layer of complexity, it ultimately
                        builds global trust.
                      </p>
                      <p className="blog-text mb-8">
                        By aligning with drug-level standards for high-risk
                        products, Indian brands are finding it significantly
                        easier to enter international markets like the US and
                        EU.
                      </p>
                      <p className="blog-text">
                        Quality-conscious third-party nutraceutical
                        manufacturing facilities are already upgrading their
                        infrastructure to meet these "pharma-grade"
                        expectations, ensuring that Indian wellness products are
                        seen as safe, effective, and scientifically sound on the
                        global stage.
                      </p>
                    </div>

                    <div className="blog-section">
                      <div className="blog-conclusion">
                        <h2 className="blog-section-title">Conclusion</h2>
                        <p className="blog-text mb-8">
                          The 2026 regulatory landscape is no longer about
                          "getting a license" and more about "maintaining
                          compliance." Whether your product stays under FSSAI or
                          moves to CDSCO, the demand for transparency is
                          absolute.
                        </p>
                        <p className="blog-text mb-8">
                          By partnering with a technologically advanced{" "}
                          <strong>
                            third-party nutraceutical manufacturing
                          </strong>{" "}
                          firm, you can focus on marketing while they handle the
                          complex evolving science of safety.
                        </p>
                        <p className="blog-text">
                          Read here:{" "}
                          <strong>
                            <Link
                              className="blog-text-link"
                              to="https://www.pharmanow.live/pharma-manufacturing/nutraceuticals-regulation-india"
                            >
                              Nutraceutical Regulatory Updates 2026
                            </Link>
                          </strong>{" "}
                          — This article provides a deep dive into the specific
                          regulatory changes and the industry's response to the
                          FSSAI-CDSCO transition in India.
                        </p>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </section>
      </div>

      <NutritionFooter />
    </>
  );
}

export default FromFSSAItoCDSCOIstheRegulationofIndianNutraceuticalsChangingIn;
